SETD9
Basic information
Region (hg38): 5:56909260-56925532
Previous symbols: [ "C5orf35" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SETD9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 8 | |||||
Total | 0 | 0 | 16 | 2 | 0 |
Variants in SETD9
This is a list of pathogenic ClinVar variants found in the SETD9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-56909667-G-A | not specified | Uncertain significance (Jun 18, 2024) | ||
5-56911180-A-G | not specified | Uncertain significance (May 15, 2023) | ||
5-56911191-G-C | not specified | Uncertain significance (Jul 31, 2023) | ||
5-56911234-C-T | not specified | Uncertain significance (Jan 03, 2022) | ||
5-56911313-T-C | Likely benign (Mar 01, 2022) | |||
5-56911368-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
5-56913115-A-G | not specified | Uncertain significance (Jan 17, 2024) | ||
5-56913899-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
5-56913987-A-G | not specified | Uncertain significance (Dec 01, 2023) | ||
5-56914893-G-C | not specified | Uncertain significance (Feb 27, 2023) | ||
5-56914938-AACATTGCCT-A | Ependymoma | Uncertain significance (Dec 29, 2017) | ||
5-56916898-G-T | not specified | Uncertain significance (Aug 14, 2023) | ||
5-56923165-T-C | not specified | Uncertain significance (Jul 30, 2023) | ||
5-56923217-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
5-56923260-A-T | not specified | Uncertain significance (May 14, 2024) | ||
5-56923371-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
5-56923381-G-C | not specified | Uncertain significance (Jun 29, 2022) | ||
5-56923428-A-C | not specified | Uncertain significance (Jun 01, 2023) | ||
5-56923498-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
5-56923550-T-A | not specified | Uncertain significance (Nov 08, 2022) | ||
5-56923556-C-T | not specified | Likely benign (Jul 12, 2023) | ||
5-56923828-T-C | not specified | Uncertain significance (Jun 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SETD9 | protein_coding | protein_coding | ENST00000285947 | 6 | 16273 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000839 | 0.934 | 125621 | 0 | 127 | 125748 | 0.000505 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.479 | 140 | 157 | 0.892 | 0.00000767 | 1931 |
Missense in Polyphen | 44 | 49.086 | 0.89639 | 618 | ||
Synonymous | -0.0287 | 60 | 59.7 | 1.00 | 0.00000307 | 584 |
Loss of Function | 1.68 | 9 | 16.3 | 0.551 | 9.03e-7 | 183 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000917 | 0.000913 |
Ashkenazi Jewish | 0.000200 | 0.000198 |
East Asian | 0.000334 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000575 | 0.000571 |
Middle Eastern | 0.000334 | 0.000326 |
South Asian | 0.00100 | 0.000980 |
Other | 0.000990 | 0.000978 |
dbNSFP
Source:
- Pathway
- Histone Modifications;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Regulation of TP53 Activity through Methylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.231
- hipred
- N
- hipred_score
- 0.269
- ghis
- 0.470
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- methylation;regulation of signal transduction by p53 class mediator
- Cellular component
- nucleoplasm
- Molecular function
- lysine N-methyltransferase activity